Cytochroma
Edinburgh
About Cytochroma
Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Funding stage: Seed
- Last round: Grant (Dec 2021)
- Website: cytochroma.uk
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cytochroma-60168 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.